Acacia Research (ACTG) Financials

$3.57 +0.07 (+2.00%)

Closing price 10/23/2025 04:00 PM Eastern

Extended Trading

$3.48 -0.09 (-2.52%)

As of 10/23/2025 07:32 PM Eastern

Annual Income Statements for Acacia Research

This table shows Acacia Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-125	67	-36
Consolidated Net Income / (Loss)	-111	69	-35
Net Income / (Loss) Continuing Operations	-111	69	-35
Total Pre-Tax Income	-127	67	-38
Total Operating Income	-40	21	-33
Total Gross Profit	35	72	30
Total Revenue	72	125	122
Operating Revenue	59	125	122
Total Cost of Revenue	37	53	93
Operating Cost of Revenue	37	53	93
Total Operating Expenses	62	51	63
Selling, General & Admin Expense	53	44	55
Marketing Expense	8.62	6.91	7.22
Research & Development Expense	0.63	0.00	0.00
Total Other Income / (Expense), net	-100	46	-5.22
Interest Expense	6.43	2.06	6.44
Other Income / (Expense), net	-94	49	1.22
Income Tax Expense	-16	-1.50	-3.45
Net Income / (Loss) Attributable to Noncontrolling Interest	14	1.87	1.36
Basic Earnings per Share	($3.13)	$0.73	($0.36)
Weighted Average Basic Shares Outstanding	42.46M	75.30M	99.21M
Diluted Earnings per Share	($3.13)	$0.58	($0.36)
Weighted Average Diluted Shares Outstanding	58.57M	99.90M	96.09M
Weighted Average Basic & Diluted Shares Outstanding	58.57M	99.90M	96.09M

This table shows Acacia Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	28	59	15	-19	1.64	69	-0.37	-8.45	-14	-13
Consolidated Net Income / (Loss)	28	-19	9.45	-19	2.76	76	-0.19	-8.83	-12	-14
Net Income / (Loss) Continuing Operations	28	-19	9.45	-19	2.76	76	-0.19	-8.83	-12	-14
Total Pre-Tax Income	29	-20	12	-20	2.57	73	-1.30	-16	-6.16	-15
Total Operating Income	-11	-15	-9.32	-13	-13	56	-2.09	-4.76	-10	-16
Total Gross Profit	48	19	4.85	-11	1.76	77	12	6.76	2.35	8.59
Total Revenue	58	20	15	-2.03	12	101	24	26	23	49
Operating Revenue	16	13	15	7.90	10	92	24	26	23	49
Total Cost of Revenue	9.93	0.72	9.96	8.94	9.85	24	12	19	21	40
Operating Cost of Revenue	9.93	0.72	9.96	8.94	9.85	24	12	19	21	40
Total Operating Expenses	17	18	14	11	13	12	14	12	13	24
Selling, General & Admin Expense	15	16	12	9.43	12	11	12	9.95	11	22
Marketing Expense	2.12	2.19	1.91	1.86	1.61	1.52	1.56	1.39	1.39	2.88
Research & Development Expense	0.16	0.14	0.22	0.21	0.17	-0.59	0.13	0.18	0.11	-0.42
Total Other Income / (Expense), net	-1.20	-12	21	2.04	14	9.00	0.79	-11	4.11	1.01
Interest Expense	1.07	-171	0.90	0.90	0.13	0.13	0.00	0.00	0.00	6.44
Other Income / (Expense), net	-0.13	-183	24	2.94	14	7.78	-28	-11	4.11	36
Income Tax Expense	0.68	-1.81	2.48	-1.65	-0.20	-2.15	-1.11	-7.06	5.50	-0.78
Net Income / (Loss) Attributable to Noncontrolling Interest	0.31	-0.19	-9.45	0.00	1.13	10	0.19	-0.38	2.34	-0.78
Basic Earnings per Share	$0.54	($0.62)	$0.12	($0.36)	($0.02)	$0.99	$0.00	($0.08)	($0.14)	($0.14)
Weighted Average Basic Shares Outstanding	38.05M	42.46M	47.97M	58.41M	94.33M	75.30M	99.75M	100.08M	99.85M	99.21M
Diluted Earnings per Share	$0.02	($0.10)	($0.07)	($0.36)	($0.03)	$1.04	$0.00	($0.08)	($0.14)	($0.14)
Weighted Average Diluted Shares Outstanding	43.54M	58.57M	89.07M	299.66M	99.89M	99.90M	99.75M	100.38M	97.37M	96.09M
Weighted Average Basic & Diluted Shares Outstanding	43.54M	58.57M	58.55M	299.66M	99.89M	99.90M	100.02M	100.38M	97.37M	96.09M

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-22	52	-65
Net Cash From Operating Activities	-37	-23	50
Net Cash From Continuing Operating Activities	-37	-23	50
Net Income / (Loss) Continuing Operations	-111	69	-35
Consolidated Net Income / (Loss)	-111	69	-35
Depreciation Expense	14	15	34
Non-Cash Adjustments To Reconcile Net Income	90	-30	3.97
Changes in Operating Assets and Liabilities, net	-30	-76	47
Net Cash From Investing Activities	184	16	-213
Net Cash From Continuing Investing Activities	184	16	-213
Purchase of Property, Plant & Equipment	-0.73	-0.19	-149
Acquisitions	-5.00	-15	-102
Purchase of Investments	-112	-13	-20
Sale and/or Maturity of Investments	302	35	58
Other Investing Activities, net	-	9.97	0.00
Net Cash From Financing Activities	-166	59	98
Net Cash From Continuing Financing Activities	-166	59	98
Repayment of Debt	-120	-68	-30
Repurchase of Common Equity	-51	0.00	-20
Payment of Dividends	-2.80	-1.40	0.00
Issuance of Debt	-	0.00	133
Issuance of Common Equity	-	0.00	15
Other Financing Activities, net	7.65	128	-0.87
Cash Interest Paid	7.23	2.51	5.06
Cash Income Taxes Paid	0.38	0.83	1.05

This table details how cash moves in and out of Acacia Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-22	46	76	-9.04	-10	-4.64	99	-52	-27	-85
Net Cash From Operating Activities	3.96	-24	-4.35	-15	1.16	-4.54	55	16	-0.57	-20
Net Cash From Continuing Operating Activities	3.96	-24	-4.35	-15	1.16	-4.54	55	16	-0.94	-20
Net Income / (Loss) Continuing Operations	28	-19	9.45	-19	2.76	76	-0.19	-8.83	-12	-14
Consolidated Net Income / (Loss)	28	-19	9.45	-19	2.76	76	-0.19	-8.83	-12	-14
Depreciation Expense	3.36	3.37	3.38	3.41	3.36	4.58	4.57	7.41	9.76	12
Non-Cash Adjustments To Reconcile Net Income	-35	5.27	-18	12	-12	-12	-8.47	10	-1.16	3.23
Changes in Operating Assets and Liabilities, net	7.36	-14	0.70	-11	7.00	-73	59	6.92	2.11	-21
Net Cash From Investing Activities	46	60	2.78	6.44	-0.60	7.56	42	-152	-7.23	-96
Net Cash From Continuing Investing Activities	46	60	2.78	6.44	-0.60	7.56	42	-152	-7.23	-96
Purchase of Property, Plant & Equipment	-0.14	-0.18	-0.08	-0.05	-0.02	-0.04	-0.27	-143	-2.23	-3.29
Acquisitions	-	-	-	-	-	-15	-	-	-5.00	-88
Purchase of Investments	-	-4.61	-5.17	-0.68	-2.84	-4.39	-16	-	-	-4.93
Net Cash From Financing Activities	-68	8.47	78	-0.67	-11	-7.72	1.83	84	-19	31
Net Cash From Continuing Financing Activities	-68	8.47	78	-0.67	-11	-7.72	1.83	84	-19	31
Repayment of Debt	-55	-	-	-	-	-7.70	-	-	-	-18
Repurchase of Common Equity	-11	-	-	-	-	-	-	-	-	-13
Issuance of Debt	-	-	0.00	-	-	-	2.50	69	-	62
Other Financing Activities, net	-1.02	9.17	79	0.03	49	-0.02	-0.67	-0.17	-	-0.02
Cash Interest Paid	0.55	1.80	0.00	1.80	0.58	0.13	0.32	0.13	2.26	2.35
Cash Income Taxes Paid	0.17	0.18	0.15	0.40	0.17	0.11	0.12	0.27	0.08	0.59

This table presents Acacia Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	483	634	756
Total Current Assets	428	555	420
Cash & Equivalents	288	340	274
Short-Term Investments	98	100	60
Accounts Receivable	8.23	81	27
Inventories, net	14	11	27
Prepaid Expenses	19	23	32
Plant, Property, & Equipment, net	3.54	2.36	24
Total Noncurrent Assets	51	77	312
Goodwill	7.54	8.99	29
Intangible Assets	37	34	55
Noncurrent Deferred & Refundable Income Taxes	0.00	2.92	20
Other Noncurrent Operating Assets	7.21	31	207
Total Liabilities & Shareholders' Equity	483	634	756
Total Liabilities	194	44	204
Total Current Liabilities	87	28	47
Accounts Payable	20	12	33
Current Deferred Revenue	1.23	0.98	1.32
Current Employee Benefit Liabilities	4.74	4.21	6.28
Other Current Liabilities	0.70	11	6.99
Total Noncurrent Liabilities	106	16	157
Long-Term Debt	0.00	11	114
Asset Retirement Reserve & Litigation Obligation	-	0.29	31
Noncurrent Deferred & Payable Income Tax Liabilities	0.74	0.00	2.61
Other Noncurrent Operating Liabilities	105	5.48	8.87
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	269	590	553
Total Preferred & Common Equity	258	568	515
Preferred Stock	0.00	0.00	0.00
Total Common Equity	258	568	515
Common Stock	663	906	910
Retained Earnings	-307	-240	-276
Treasury Stock	-98	-98	-119
Accumulated Other Comprehensive Income / (Loss)	-	0.00	-1.18
Noncontrolling Interest	11	21	38

This table presents Acacia Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	485	557	535	529	632	754	708
Total Current Assets	427	505	486	484	553	494	458
Cash & Equivalents	242	364	355	345	439	387	360
Short-Term Investments	159	97	90	101	60	55	51
Accounts Receivable	7.04	8.67	6.27	5.90	15	19	11
Inventories, net	14	15	14	12	9.88	12	12
Prepaid Expenses	5.17	20	21	20	29	21	24
Plant, Property, & Equipment, net	3.70	3.28	2.95	2.65	2.09	2.32	2.37
Total Noncurrent Assets	54	48	46	42	76	257	248
Goodwill	7.47	7.54	7.54	7.54	8.99	8.99	8.99
Intangible Assets	40	34	31	28	30	36	31
Noncurrent Deferred & Refundable Income Taxes	-	-	-	0.32	6.57	14	8.42
Other Noncurrent Operating Assets	7.21	6.97	7.84	6.63	31	198	199
Total Liabilities & Shareholders' Equity	485	557	535	529	632	754	708
Total Liabilities	184	179	176	26	42	157	129
Total Current Liabilities	85	90	78	21	26	44	28
Accounts Payable	14	21	10	14	8.69	18	14
Current Deferred Revenue	1.40	1.21	1.02	1.15	1.07	0.91	1.27
Current Employee Benefit Liabilities	5.07	5.49	5.51	5.20	4.62	3.98	4.97
Other Current Liabilities	3.26	1.06	0.58	1.30	3.01	6.41	7.76
Total Noncurrent Liabilities	99	89	98	4.12	16	113	101
Long-Term Debt	-	-	-	-	13	82	70
Asset Retirement Reserve & Litigation Obligation	-	-	-	-	-	28	28
Other Noncurrent Operating Liabilities	95	88	98	3.62	2.89	2.93	3.02
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	282	356	335	504	590	597	579
Total Preferred & Common Equity	258	345	324	493	568	561	540
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	258	345	324	493	568	561	540
Common Stock	644	740	739	905	906	907	908
Retained Earnings	-288	-297	-316	-314	-240	-248	-262
Treasury Stock	-98	-98	-98	-98	-98	-98	-106
Noncontrolling Interest	25	11	11	11	21	36	38

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	51.82%	72.97%	-2.23%
EBITDA Growth	-152.22%	170.05%	-97.78%
EBIT Growth	-161.00%	151.93%	-145.63%
NOPAT Growth	-324.11%	176.26%	-207.69%
Net Income Growth	-173.78%	162.13%	-150.34%
EPS Growth	-263.87%	118.53%	-162.07%
Operating Cash Flow Growth	-380.17%	39.72%	322.71%
Free Cash Flow Firm Growth	-384.48%	-187.79%	-6.18%
Invested Capital Growth	44.18%	452.55%	107.73%
Revenue Q/Q Growth	-4.14%	183.60%	-32.95%
EBITDA Q/Q Growth	-128.18%	147.31%	-93.66%
EBIT Q/Q Growth	-132.42%	136.28%	-1,111.74%
NOPAT Q/Q Growth	-628.25%	161.70%	-154.15%
Net Income Q/Q Growth	-198.92%	374.09%	-163.29%
EPS Q/Q Growth	-621.67%	203.57%	-143.90%
Operating Cash Flow Q/Q Growth	-514.57%	46.03%	-23.87%
Free Cash Flow Firm Q/Q Growth	70.36%	-40.49%	-42.31%
Invested Capital Q/Q Growth	-16.93%	178.15%	40.05%
Profitability Metrics	-	-	-
Gross Margin	48.31%	57.77%	24.24%
EBITDA Margin	-166.22%	67.32%	1.53%
Operating Margin	-55.43%	16.74%	-26.92%
EBIT Margin	-185.03%	55.55%	-25.92%
Profit (Net Income) Margin	-153.39%	55.10%	-28.37%
Tax Burden Percent	87.25%	102.23%	90.96%
Interest Burden Percent	95.02%	97.03%	120.31%
Effective Tax Rate	0.00%	-2.23%	0.00%
Return on Invested Capital (ROIC)	0.00%	37.29%	-9.35%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	24.85%	-5.76%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-21.61%	3.27%
Return on Equity (ROE)	-30.21%	15.69%	-6.08%
Cash Return on Invested Capital (CROIC)	0.00%	-115.01%	-79.37%
Operating Return on Assets (OROA)	-20.88%	12.45%	-4.56%
Return on Assets (ROA)	-17.31%	12.35%	-4.99%
Return on Common Equity (ROCE)	-27.87%	14.75%	-5.76%
Return on Equity Simple (ROE_SIMPLE)	-42.95%	12.13%	-6.74%
Net Operating Profit after Tax (NOPAT)	-28	21	-23
NOPAT Margin	-38.80%	17.11%	-18.84%
Net Nonoperating Expense Percent (NNEP)	-19.24%	12.44%	-3.59%
Return On Investment Capital (ROIC_SIMPLE)	-	3.57%	-3.46%
Cost of Revenue to Revenue	51.69%	42.23%	75.76%
SG&A Expenses to Revenue	72.84%	35.51%	45.26%
R&D to Revenue	0.87%	0.00%	0.00%
Operating Expenses to Revenue	85.62%	41.04%	51.16%
Earnings before Interest and Taxes (EBIT)	-134	69	-32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-120	84	1.87
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.71	0.69	0.82
Price to Tangible Book Value (P/TBV)	0.86	0.74	0.98
Price to Revenue (P/Rev)	2.53	3.13	3.45
Price to Earnings (P/E)	0.00	5.84	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	17.13%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.72
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	1.97
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	128.94
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	4.80
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.21	0.02	0.21
Long-Term Debt to Equity	0.00	0.02	0.21
Financial Leverage	-1.17	-0.87	-0.57
Leverage Ratio	1.75	1.27	1.22
Compound Leverage Factor	1.66	1.23	1.46
Debt to Total Capital	17.29%	1.75%	17.10%
Short-Term Debt to Total Capital	17.29%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	1.75%	17.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	8.86%	3.56%	5.67%
Common Equity to Total Capital	73.86%	94.69%	77.23%
Debt to EBITDA	-0.50	0.13	61.09
Net Debt to EBITDA	2.71	-5.10	-117.78
Long-Term Debt to EBITDA	0.00	0.13	61.09
Debt to NOPAT	-2.15	0.49	-4.95
Net Debt to NOPAT	11.61	-20.06	9.54
Long-Term Debt to NOPAT	0.00	0.49	-4.95
Altman Z-Score	-0.24	6.37	1.35
Noncontrolling Interest Sharing Ratio	7.73%	5.95%	5.18%
Liquidity Ratios	-	-	-
Current Ratio	4.91	20.06	8.89
Quick Ratio	4.52	18.83	7.64
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-64	-184	-196
Operating Cash Flow to CapEx	-5,100.55%	-11,907.94%	33.71%
Free Cash Flow to Firm to Interest Expense	-9.95	-89.32	-30.39
Operating Cash Flow to Interest Expense	-5.80	-10.91	7.78
Operating Cash Flow Less CapEx to Interest Expense	-5.92	-11.00	-15.30
Efficiency Ratios	-	-	-
Asset Turnover	0.11	0.22	0.18
Accounts Receivable Turnover	8.15	2.82	2.28
Inventory Turnover	3.23	4.20	4.83
Fixed Asset Turnover	18.74	42.46	9.33
Accounts Payable Turnover	2.35	3.33	4.18
Days Sales Outstanding (DSO)	44.78	129.52	160.35
Days Inventory Outstanding (DIO)	113.01	86.86	75.64
Days Payable Outstanding (DPO)	155.03	109.72	87.28
Cash Conversion Cycle (CCC)	2.76	106.66	148.71
Capital & Investment Metrics	-	-	-
Invested Capital	-45	160	333
Invested Capital Turnover	-1.14	2.18	0.50
Increase / (Decrease) in Invested Capital	36	206	173
Enterprise Value (EV)	-111	-16	241
Market Capitalization	183	392	423
Book Value per Share	$6.08	$5.69	$5.29
Tangible Book Value per Share	$5.04	$5.26	$4.42
Total Capital	350	600	667
Total Debt	60	11	114
Total Long-Term Debt	0.00	11	114
Net Debt	-326	-429	-220
Capital Expenditures (CapEx)	0.73	0.19	149
Debt-free, Cash-free Net Working Capital (DFCFNWC)	15	87	39
Debt-free Net Working Capital (DFNWC)	401	527	373
Net Working Capital (NWC)	341	527	373
Net Nonoperating Expense (NNE)	83	-48	12
Net Nonoperating Obligations (NNO)	-335	-429	-220
Total Depreciation and Amortization (D&A)	14	15	34
Debt-free, Cash-free Net Working Capital to Revenue	20.85%	69.52%	32.00%
Debt-free Net Working Capital to Revenue	554.75%	421.16%	304.88%
Net Working Capital to Revenue	471.17%	421.16%	304.88%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($3.13)	$0.73	($0.36)
Adjusted Weighted Average Basic Shares Outstanding	42.46M	75.30M	99.21M
Adjusted Diluted Earnings per Share	($3.13)	$0.58	($0.36)
Adjusted Weighted Average Diluted Shares Outstanding	58.57M	99.90M	96.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	58.57M	99.90M	96.09M
Normalized Net Operating Profit after Tax (NOPAT)	-28	15	-23
Normalized NOPAT Margin	-38.80%	11.71%	-18.84%
Pre Tax Income Margin	-175.80%	53.90%	-31.19%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-20.81	33.68	-4.92
NOPAT to Interest Expense	-4.36	10.37	-3.58
EBIT Less CapEx to Interest Expense	-20.92	33.59	-28.01
NOPAT Less CapEx to Interest Expense	-4.48	10.28	-26.67
Payout Ratios	-	-	-
Dividend Payout Ratio	-2.52%	2.03%	0.00%
Augmented Payout Ratio	-48.48%	2.03%	-58.47%

This table displays calculated financial ratios and metrics derived from Acacia Research's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	3,535.65%	-13.67%	9.60%	88.98%	-79.82%	410.47%	64.29%	1,372.18%	100.79%	-51.51%
EBITDA Growth	-128.50%	-154.96%	-80.27%	15.00%	156.00%	135.22%	-245.64%	-37.28%	-20.54%	-52.65%
EBIT Growth	-144.94%	-156.49%	-83.43%	10.26%	110.18%	132.30%	-312.52%	-65.71%	-626.50%	-67.82%
NOPAT Growth	12.74%	-136.32%	-23.97%	-120.97%	-27.60%	665.36%	80.21%	62.02%	49.23%	-119.22%
Net Income Growth	-68.36%	-109.08%	112.89%	60.46%	-90.27%	506.37%	-102.00%	52.98%	-522.05%	-118.57%
EPS Growth	-97.67%	-102.75%	95.65%	75.00%	-250.00%	1,140.00%	100.00%	77.78%	-366.67%	-113.46%
Operating Cash Flow Growth	416.15%	-205.02%	-37.50%	-2.66%	-70.67%	80.86%	1,360.96%	209.09%	-149.22%	-345.91%
Free Cash Flow Firm Growth	-166.25%	-221.36%	90.49%	73.92%	52.40%	-220.90%	-549.44%	-421.46%	-69.25%	-24.03%
Invested Capital Growth	85.06%	44.18%	31.43%	62.11%	248.21%	452.55%	457.02%	1,019.60%	312.59%	107.73%
Revenue Q/Q Growth	412.10%	-65.69%	-24.98%	-113.72%	671.59%	767.61%	-77.68%	6.24%	-9.78%	109.54%
EBITDA Q/Q Growth	-11.30%	-2,295.89%	109.06%	-135.18%	173.34%	1,406.57%	-142.71%	66.84%	142.45%	797.83%
EBIT Q/Q Growth	-7.54%	-1,616.97%	107.19%	-167.57%	112.20%	5,345.90%	-154.49%	47.31%	61.23%	432.81%
NOPAT Q/Q Growth	-179.66%	8.25%	27.50%	-18.78%	-61.49%	506.53%	-102.44%	-127.98%	-115.89%	-53.90%
Net Income Q/Q Growth	159.79%	-165.43%	150.85%	-298.78%	114.71%	2,633.53%	-100.25%	-4,571.43%	-32.03%	-20.30%
EPS Q/Q Growth	101.39%	-600.00%	30.00%	-414.29%	91.67%	3,566.67%	-100.00%	0.00%	-75.00%	0.00%
Operating Cash Flow Q/Q Growth	127.48%	-700.20%	81.68%	-239.69%	107.85%	-491.72%	1,306.84%	-70.61%	-103.54%	-3,448.51%
Free Cash Flow Firm Q/Q Growth	-18.85%	80.15%	55.01%	-145.60%	-116.95%	-33.86%	7.49%	-97.20%	29.58%	1.91%
Invested Capital Q/Q Growth	42.83%	-16.93%	35.78%	11.76%	323.67%	178.15%	-34.97%	127.29%	0.35%	40.05%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	82.74%	96.35%	32.73%	0.00%	15.18%	76.09%	49.16%	26.16%	10.09%	17.59%
EBITDA Margin	-14.07%	-982.83%	118.71%	0.00%	39.05%	67.80%	-105.23%	-32.84%	15.45%	66.21%
Operating Margin	-19.76%	-73.74%	-62.99%	0.00%	-113.30%	55.54%	-8.58%	-18.41%	-44.07%	-32.37%
EBIT Margin	-19.98%	-999.93%	95.87%	0.00%	10.08%	63.26%	-124.01%	-61.50%	-26.43%	41.97%
Profit (Net Income) Margin	49.37%	-94.16%	63.82%	0.00%	23.79%	74.96%	-0.78%	-34.17%	-50.01%	-28.71%
Tax Burden Percent	97.66%	91.11%	79.19%	91.95%	107.68%	102.92%	14.56%	55.56%	189.24%	94.76%
Interest Burden Percent	-253.02%	10.34%	84.07%	212.99%	219.23%	115.13%	4.30%	100.00%	100.00%	-72.19%
Effective Tax Rate	2.34%	0.00%	20.81%	0.00%	-7.68%	-2.92%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	-574.45%	124.62%	-22.88%	-20.85%	-38.12%	-11.24%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	-578.76%	119.93%	-23.17%	-19.37%	-36.98%	-10.33%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	565.28%	-104.26%	21.37%	15.09%	26.89%	5.87%
Return on Equity (ROE)	41.78%	-30.21%	-7.64%	0.15%	-9.17%	20.35%	-1.51%	-5.76%	-11.23%	-5.37%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	-227.69%	-115.01%	-98.43%	-92.98%	-93.13%	-79.37%
Operating Return on Assets (OROA)	-2.44%	-112.84%	11.59%	0.00%	0.88%	14.18%	-29.82%	-16.30%	-7.80%	7.39%
Return on Assets (ROA)	6.03%	-10.63%	7.71%	0.00%	2.07%	16.80%	-0.19%	-9.06%	-14.75%	-5.05%
Return on Common Equity (ROCE)	37.49%	-27.87%	-7.03%	0.13%	-8.55%	19.14%	-1.43%	-5.34%	-10.71%	-5.09%
Return on Equity Simple (ROE_SIMPLE)	43.52%	0.00%	-8.19%	0.15%	-5.11%	0.00%	10.43%	12.35%	10.15%	0.00%
Net Operating Profit after Tax (NOPAT)	-11	-10	-7.38	-8.77	-14	58	-1.46	-3.33	-7.19	-11
NOPAT Margin	-19.30%	-51.62%	-49.88%	0.00%	-122.00%	57.17%	-6.01%	-12.89%	-30.85%	-22.66%
Net Nonoperating Expense Percent (NNEP)	9.45%	-1.95%	4.15%	-2.71%	4.31%	4.69%	0.29%	-1.48%	-1.14%	-0.91%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	9.59%	-	-	-	-1.66%
Cost of Revenue to Revenue	17.26%	3.65%	67.27%	0.00%	84.82%	23.91%	50.84%	73.84%	89.91%	82.41%
SG&A Expenses to Revenue	26.15%	80.42%	81.33%	0.00%	99.97%	11.28%	50.79%	38.51%	47.72%	44.91%
R&D to Revenue	0.27%	0.68%	1.46%	0.00%	1.48%	-0.59%	0.55%	0.69%	0.46%	-0.86%
Operating Expenses to Revenue	30.10%	92.21%	95.72%	0.00%	115.34%	12.20%	57.74%	44.57%	54.15%	49.95%
Earnings before Interest and Taxes (EBIT)	-11	-197	14	-9.59	1.17	64	-30	-16	-6.16	21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-8.09	-194	18	-6.18	4.53	68	-26	-8.49	3.60	32
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.60	0.71	0.66	0.75	0.74	0.69	0.94	0.89	0.87	0.82
Price to Tangible Book Value (P/TBV)	0.74	0.86	0.74	0.85	0.80	0.74	1.01	0.97	0.93	0.98
Price to Revenue (P/Rev)	2.05	2.53	3.07	2.71	8.27	3.13	3.73	2.94	2.56	3.45
Price to Earnings (P/E)	0.00	0.00	5.57	2.92	6.41	5.84	10.38	8.13	10.17	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	17.95%	34.20%	15.59%	17.13%	9.63%	12.30%	9.83%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.66	0.75	0.70	0.72
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	0.00	0.00	0.48	1.04	0.91	1.97
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	2.09	5.84	5.61	128.94
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	4.08	16.94	52.72	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	2.22	4.18	3.88	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	1.86	2.62	2.51	4.80
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.20	0.21	0.16	0.17	0.00	0.02	0.02	0.14	0.12	0.21
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.02	0.02	0.14	0.12	0.21
Financial Leverage	-1.56	-1.17	-1.10	-1.15	-0.98	-0.87	-0.92	-0.78	-0.73	-0.57
Leverage Ratio	2.30	1.75	1.65	1.70	1.26	1.27	1.23	1.35	1.14	1.22
Compound Leverage Factor	-5.82	0.18	1.39	3.63	2.76	1.46	0.05	1.35	1.14	-0.88
Debt to Total Capital	16.93%	17.29%	13.99%	14.43%	0.00%	1.75%	2.16%	12.08%	10.79%	17.10%
Short-Term Debt to Total Capital	16.93%	17.29%	13.99%	14.43%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	1.75%	2.16%	12.08%	10.79%	17.10%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	11.94%	8.86%	7.42%	8.16%	2.19%	3.56%	3.54%	5.31%	5.92%	5.67%
Common Equity to Total Capital	71.13%	73.86%	78.59%	77.41%	97.81%	94.69%	94.30%	82.61%	83.29%	77.23%
Debt to EBITDA	0.14	-0.50	-0.32	-0.32	0.00	0.13	0.40	2.70	2.38	61.09
Net Debt to EBITDA	-0.80	2.71	2.09	2.02	0.00	-5.10	-14.85	-11.85	-11.58	-117.78
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.13	0.40	2.70	2.38	61.09
Debt to NOPAT	11.55	-2.15	-2.14	-0.50	0.00	0.49	0.42	1.94	1.64	-4.95
Net Debt to NOPAT	-63.97	11.61	13.98	3.15	0.00	-20.06	-15.75	-8.49	-8.01	9.54
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.49	0.42	1.94	1.64	-4.95
Altman Z-Score	0.59	-0.67	1.12	1.03	8.87	6.34	8.12	2.33	2.61	1.58
Noncontrolling Interest Sharing Ratio	10.28%	7.73%	8.05%	11.86%	6.75%	5.95%	5.57%	7.35%	4.57%	5.18%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.00	4.91	5.60	6.24	22.60	20.06	21.40	11.17	16.39	8.89
Quick Ratio	4.78	4.52	5.21	5.80	21.08	18.83	19.88	10.42	15.10	7.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-232	-46	-21	-51	-111	-148	-135	-266	-187	-184
Operating Cash Flow to CapEx	2,785.21%	-13,187.78%	-5,239.76%	-27,357.41%	7,733.33%	-12,281.08%	20,310.74%	11.28%	-25.56%	-615.87%
Free Cash Flow to Firm to Interest Expense	-216.82	0.00	-23.07	-56.66	-851.03	-1,113.50	0.00	0.00	0.00	-28.53
Operating Cash Flow to Interest Expense	3.69	0.00	-4.83	-16.41	8.92	-34.17	0.00	0.00	0.00	-3.15
Operating Cash Flow Less CapEx to Interest Expense	3.56	0.00	-4.92	-16.47	8.81	-34.44	0.00	0.00	0.00	-3.66
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.12	0.11	0.12	0.16	0.09	0.22	0.24	0.27	0.30	0.18
Accounts Receivable Turnover	5.20	8.15	8.27	9.02	6.82	2.82	11.89	13.64	21.94	2.28
Inventory Turnover	0.00	3.23	2.41	2.27	2.25	4.20	4.49	4.97	6.22	4.83
Fixed Asset Turnover	0.00	18.74	20.56	26.35	13.90	42.46	53.26	64.85	72.78	9.33
Accounts Payable Turnover	4.90	2.35	1.77	2.62	2.09	3.33	3.71	4.56	5.52	4.18
Days Sales Outstanding (DSO)	70.13	44.78	44.14	40.46	53.52	129.52	30.71	26.77	16.64	160.35
Days Inventory Outstanding (DIO)	0.00	113.01	151.33	160.95	162.12	86.86	81.30	73.41	58.68	75.64
Days Payable Outstanding (DPO)	74.48	155.03	206.48	139.42	174.28	109.72	98.46	79.98	66.12	87.28
Cash Conversion Cycle (CCC)	-4.36	2.76	-11.00	62.00	41.36	106.66	13.55	20.20	9.19	148.71
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-39	-45	-29	-26	58	160	104	237	238	333
Invested Capital Turnover	-0.50	-1.14	-2.05	-1.92	4.71	2.18	3.81	1.62	1.24	0.50
Increase / (Decrease) in Invested Capital	221	36	13	42	96	206	133	263	180	173
Enterprise Value (EV)	-142	-111	-142	-107	-70	-16	68	177	165	241
Market Capitalization	155	183	226	244	365	392	532	501	468	423
Book Value per Share	$6.73	$6.08	$5.88	$5.54	$4.93	$5.69	$5.69	$5.61	$5.38	$5.29
Tangible Book Value per Share	$5.50	$5.04	$5.18	$4.89	$4.58	$5.26	$5.30	$5.16	$4.98	$4.42
Total Capital	362	350	439	419	504	600	603	679	649	667
Total Debt	61	60	61	60	0.00	11	13	82	70	114
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	11	13	82	70	114
Net Debt	-340	-326	-400	-384	-446	-429	-485	-360	-341	-220
Capital Expenditures (CapEx)	0.14	0.18	0.08	0.05	0.02	0.04	0.27	143	2.23	3.29
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1.93	15	15	24	17	87	29	7.82	19	39
Debt-free Net Working Capital (DFNWC)	403	401	476	468	463	527	527	450	430	373
Net Working Capital (NWC)	342	341	415	408	463	527	527	450	430	373
Net Nonoperating Expense (NNE)	-39	8.39	-17	10	-17	-18	-1.27	5.50	4.47	2.96
Net Nonoperating Obligations (NNO)	-340	-335	-406	-384	-446	-429	-485	-360	-341	-220
Total Depreciation and Amortization (D&A)	3.40	3.37	3.38	3.41	3.36	4.58	4.57	7.41	9.76	12
Debt-free, Cash-free Net Working Capital to Revenue	2.56%	20.85%	19.87%	26.27%	38.58%	69.52%	20.21%	4.58%	10.32%	32.00%
Debt-free Net Working Capital to Revenue	534.29%	554.75%	647.00%	520.37%	1,049.63%	421.16%	369.10%	263.42%	235.56%	304.88%
Net Working Capital to Revenue	452.97%	471.17%	563.67%	453.22%	1,049.63%	421.16%	369.10%	263.42%	235.56%	304.88%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.54	($0.62)	$0.12	($0.36)	($0.02)	$0.99	$0.00	($0.08)	($0.14)	($0.14)
Adjusted Weighted Average Basic Shares Outstanding	38.05M	42.46M	47.97M	58.41M	94.33M	75.30M	99.75M	100.08M	99.85M	99.21M
Adjusted Diluted Earnings per Share	$0.02	($0.10)	($0.07)	($0.36)	($0.03)	$1.04	$0.00	($0.08)	($0.14)	($0.14)
Adjusted Weighted Average Diluted Shares Outstanding	43.54M	58.57M	89.07M	299.66M	99.89M	99.90M	99.75M	100.38M	97.37M	96.09M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	43.54M	58.57M	58.55M	299.66M	99.89M	99.90M	100.02M	100.38M	97.37M	96.09M
Normalized Net Operating Profit after Tax (NOPAT)	-11	-10	-7.38	-8.77	-9.21	39	-1.46	-3.33	-7.19	-11
Normalized NOPAT Margin	-19.30%	-51.62%	-49.88%	0.00%	-79.31%	38.88%	-6.01%	-12.89%	-30.85%	-22.66%
Pre Tax Income Margin	50.55%	-103.35%	80.59%	0.00%	22.09%	72.83%	-5.34%	-61.50%	-26.43%	-30.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-10.72	0.00	15.77	-10.65	9.00	479.08	0.00	0.00	0.00	3.18
NOPAT to Interest Expense	-10.35	0.00	-8.20	-9.74	-108.95	432.92	0.00	0.00	0.00	-1.72
EBIT Less CapEx to Interest Expense	-10.85	0.00	15.68	-10.71	8.88	478.80	0.00	0.00	0.00	2.67
NOPAT Less CapEx to Interest Expense	-10.49	0.00	-8.30	-9.80	-109.06	432.64	0.00	0.00	0.00	-2.23
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	2.47%	-2.52%	-9.92%	577.32%	-8.35%	2.03%	1.18%	0.00%	0.00%	0.00%
Augmented Payout Ratio	51.51%	-48.48%	-9.92%	577.32%	-8.35%	2.03%	1.18%	0.00%	13.32%	-58.47%

Financials Breakdown Chart

Key Financial Trends

Acacia Research (NASDAQ:ACTG) has experienced notable volatility in its financial performance over the past few years, with mixed trends in revenue, profitability, and cash flows.

Key Positive Trends:

The company had a strong Q4 2023 with consolidated net income of $75.5 million, a significant turnaround from losses in previous quarters.
Cash and equivalents consistently remained high, peaking at over $438 million in Q1 2024, providing liquidity for operations and investments.
Investments and acquisitions appear to be a vital part of the company’s growth strategy, with strategic acquisition spending of $15.4 million in Q4 2023 and continued investment activity in 2024.
Operating revenue showed growth in 2024 Q4 to approximately $48.8 million, more than doubling from Q3 2024 ($23.3 million), indicating improving top-line momentum.
Other income and investment revenues in some quarters, e.g., Q1 2024, contributed positively with $28.9 million in interest and investment income, aiding overall profitability.

Neutral Factors:

Weighted average shares outstanding have gradually increased, which may dilute earnings per share but supports capital raising.
Gross profit fluctuated significantly, with a high of $76.6 million in Q4 2023 but much lower amounts in 2024 quarters, reflecting variability in core business performance.
Depreciation and non-cash adjustments have varied quarter-to-quarter, influencing operating cash flow reconciliation.
The company maintains substantial goodwill and intangible assets on the balance sheet, reflective of previous acquisitions, which necessitate ongoing impairment reviews.

Key Negative Trends:

Acacia has recorded persistent net losses in most quarters during 2024, including a loss of $14 million in Q4 2024 and significant losses in previous quarters.
Operating expenses remain high relative to revenue, with SG&A and marketing expenses consistently exceeding gross profits in 2024, leading to negative operating income.
Net cash from operating activities was negative in Q3 and Q4 2024 (-$0.9 million and -$20.3 million respectively), signaling cash burn in core operations.
Debt levels increased with long-term debt rising to $70 million by Q3 2024, while the company engaged in significant debt issuance ($62 million in Q4 2024), adding interest expense risk.
Net cash used in investing activities surged in 2024, predominantly driven by large acquisition spending ($87.7 million in Q4 2024), which could pressure liquidity if returns are delayed.
Interest expense jumped sharply to $6.4 million in Q4 2024 from relatively negligible amounts earlier, compressing net income further.
Earnings per share remained negative in 2024, specifically -$0.14 for Q3 and Q4 2024, underscoring ongoing profitability challenges despite fluctuating revenue.

Overall, Acacia Research is in a transitional phase with strong liquidity and investment activity but faces short-term profitability and cash flow challenges due to high operating costs and increasing debt levels. Investors should watch for the company’s ability to convert acquisitions into profitable growth and manage expenses while sustaining positive cash flow.

10/24/25 07:19 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Acacia Research's Financials

When does Acacia Research's financial year end?

According to the most recent income statement we have on file, Acacia Research's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Acacia Research's net income changed over the last 2 years?

Acacia Research's net income appears to be on a downward trend, with a most recent value of -$34.70 million in 2024, falling from -$110.94 million in 2022. The previous period was $68.93 million in 2023. View Acacia Research's forecast to see where analysts expect Acacia Research to go next.

What is Acacia Research's operating income?

Acacia Research's total operating income in 2024 was -$32.93 million, based on the following breakdown:

Total Gross Profit: $29.65 million
Total Operating Expenses: $62.58 million

How has Acacia Research's revenue changed over the last 2 years?

Over the last 2 years, Acacia Research's total revenue changed from $72.33 million in 2022 to $122.31 million in 2024, a change of 69.1%.

How much debt does Acacia Research have?

Acacia Research's total liabilities were at $203.78 million at the end of 2024, a 363.8% increase from 2023, and a 5.2% increase since 2022.

How much cash does Acacia Research have?

In the past 2 years, Acacia Research's cash and equivalents has ranged from $273.88 million in 2024 to $340.09 million in 2023, and is currently $273.88 million as of their latest financial filing in 2024.

How has Acacia Research's book value per share changed over the last 2 years?

Over the last 2 years, Acacia Research's book value per share changed from 6.08 in 2022 to 5.29 in 2024, a change of -13.1%.

Related Companies

This page (NASDAQ:ACTG) was last updated on 10/24/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acacia Research (ACTG) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Acacia Research's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acacia Research (ACTG) Financials

Annual Income Statements for Acacia Research

Quarterly Income Statements for Acacia Research

Annual Cash Flow Statements for Acacia Research

Quarterly Cash Flow Statements for Acacia Research

Annual Balance Sheets for Acacia Research

Quarterly Balance Sheets for Acacia Research

Annual Metrics And Ratios for Acacia Research

Quarterly Metrics And Ratios for Acacia Research

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Acacia Research's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools